HomeInsightsStock Comparison

Indoco Remedies Ltd vs Innova Captab Ltd Stock Comparison

Indoco Remedies Ltd vs Innova Captab Ltd Stock Comparison

Last Updated on: May 07, 2026

Key Highlights

  • The Latest Trading Price of Indoco Remedies Ltd is ₹ 255.8 as of 07 May 14:52 . The P/E Ratio of Indoco Remedies Ltd changed from 28.6 on March 2021 to 0 on March 2025 . This represents a CAGR of -100.00% over 5 yearsThe P/E Ratio of Innova Captab Ltd changed from 27.2 on March 2024 to 39.2 on March 2025 . This represents a CAGR of 20.05% over 2 years The Market Cap of Indoco Remedies Ltd changed from ₹ 2658 crore on March 2021 to ₹ 2152 crore on March 2025 . This represents a CAGR of -4.14% over 5 yearsThe Market Cap of Innova Captab Ltd changed from ₹ 2564 crore on March 2024 to ₹ 5021 crore on March 2025 . This represents a CAGR of 39.93% over 2 years The revenue of Indoco Remedies Ltd for the Mar '26 is ₹ 479.31 crore as compare to the Dec '25 revenue of ₹ 446.34 crore. This represent the growth of 7.39% The revenue of Innova Captab Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 revenue of ₹ 451.95 crore. This represent the decline of -100% The ebitda of Indoco Remedies Ltd for the Mar '26 is ₹ 53.41 crore as compare to the Dec '25 ebitda of ₹ 26.34 crore. This represent the growth of 102.77% The ebitda of Innova Captab Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 ebitda of ₹ 71.05 crore. This represent the decline of -100% The net profit of Indoco Remedies Ltd changed from ₹ 1.82 crore to ₹ -23.68 crore over 8 quarters. This represents a CAGR of NaN% The net profit of Innova Captab Ltd changed from ₹ 29.48 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of -100.00% The Dividend Payout of Indoco Remedies Ltd changed from 14.96 % on March 2021 to -21.11 % on March 2025 . This represents a CAGR of NaN% over 5 yearsThe Dividend Payout of Innova Captab Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Indoco Remedies Ltd

  • Indoco Remedies Limited, incorporated on August 23, 1947 is a Mumbai-based pharmaceutical company focused on formulations, with some presence in contract manufacturing and research.
  • The Company headquartered in Mumbai, is a fully integrated, research-oriented pharma Company with presence in 55 countries.
  • The Company is engaged in the manufacturing and marketing of pharmaceutical Formulations (Finished Dosage Forms) and Active Pharmaceutical Ingredients (APIs). Indoco, a USD 212 million company has 11 manufacturing facilities, 7 of which are for FDFs and 4 for APIs, supported by a state-of-the-art R&D Centre and a CRO facility. Currently, Indoco has a presence in therapeutic segments including anti-infective, anti-cold preparation, opthalmic, antispasmodic, stomatology, anti-inflammatory and anti-fungal.

About Innova Captab Ltd

  • Innova Captab Limited was incorporated as Harun Health Care Private Limited', dated January 3, 2005, as a Private Limited Company at Mumbai.
  • Thereafter, the name of the Company was changed from Harun Health Care Private Limited' to Innova Captab Private Limited', and a fresh Certificate of Incorporation dated February 2, 2010, was issued by RoC to the Company.
  • Subsequently, Company got converted to a Public Company on July 12, 2018, and the name was changed to Innova Captab Limited', dated July 26, 2018. The Company is an integrated pharmaceutical company in India with a presence across the pharmaceuticals value chain including research and development, manufacturing, drug distribution and marketing and exports.
  • Their business includes contract development and manufacturing organization (CDMO) business providing manufacturing services to Indian pharmaceutical companies, domestic branded generics business and an international branded generics business.

FAQs for the comparison of Indoco Remedies Ltd and Innova Captab Ltd

Which company has a larger market capitalization, Indoco Remedies Ltd or Innova Captab Ltd?

Market cap of Indoco Remedies Ltd is 2,104 Cr while Market cap of Innova Captab Ltd is 5,010 Cr

What are the key factors driving the stock performance of Indoco Remedies Ltd and Innova Captab Ltd?

The stock performance of Indoco Remedies Ltd and Innova Captab Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Indoco Remedies Ltd and Innova Captab Ltd?

As of May 7, 2026, the Indoco Remedies Ltd stock price is INR ₹227.95. On the other hand, Innova Captab Ltd stock price is INR ₹875.5.

How do dividend payouts of Indoco Remedies Ltd and Innova Captab Ltd compare?

To compare the dividend payouts of Indoco Remedies Ltd and Innova Captab Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions